New York, NY / July 28, 2014 / Cocrystal Pharma, Inc. (OTCBB: COCP) today published a new blog post on The Chairman’s Blog, written by the Company’s Chairman and CEO, Dr. Gary Wilcox. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
In honor of World Hepatitis Day, Dr. Wilcox reflects on the hepatitis C virus (HCV) as it remains a global medical concern of pandemic proportions. With an estimated 150 to 200 million people living with chronic hepatitis C worldwide, Dr. Wilcox blogs about the need for continued efforts to develop a cure for the virus. He writes, "Our goal is to bring the world closer to eradicating, not just treating, HCV." Read the full blog post from Dr. Gary Wilcox on TheChairmansBlog.com (http://www.thechairmansblog.com/cocrystal-pharma/gary-wilcox/world-hepatitis-day-continued-global-unmet-medical-need/).
About Cocrystal Pharma, Inc.
Cocrystal Pharma is a biopharma company that seeks to develop novel technologies and approaches to create first-in-class and best-in-class broad-spectrum antiviral therapeutics for the treatment and prophylaxis of viral diseases in humans. www.cocrystalpharma.com
TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com
SOURCE: The Chairmans Blog